Could less radiation be just as effective for HPV throat cancer?
NCT ID NCT07418034
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study is for people with HPV-related oropharyngeal (throat) cancer, which often responds well to treatment. The goal is to see if lowering the radiation dose to certain areas can reduce side effects like dry mouth without hurting the chance of curing the cancer. About 132 participants will receive either reduced radiation to low-risk lymph nodes, a lower dose to the tumor itself, or both, based on their individual risk factors and a blood test. The study aims to keep cancer control rates high while making treatment easier to tolerate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital peer support: a new weapon against cancer treatment anxiety?
- A gentler path after surgery for HPV throat cancer?
- Can targeted radiation boost Immunotherapy's power against head and neck cancer?
- Could a simple mouthwash protect cancer patients from Radiation's painful side effects?
- Can tailored nutrition boost recovery from head and neck surgery?
- Can less radiation be safer for throat cancer?